TJTomasz Janus

Tomasz Janus

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomasz Janus has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hemorrhagic stroke caused by xylometazoline poisoning

    by Barbara Potocka Banaś, Katarzyna Brzeźniakiewicz‐Janus, Sławomir Majdanik, Mirosław Parafiniuk, Sylwester Łużny, Agnieszka Stachowicz, Tomasz Janus

    An increase in the use of over-the-counter medications has been observed in recent years. This also concerns xylometazoline, approved for the treatment of allergic rhinitis or upper respiratory tract infections. We present the fatal case of a 40 year-old-woman with a massive hemorrhagic stroke. Initial toxicology tests of biological material collected during autopsy revealed the presence of xylometazoline. No other significant toxicology findings were noted. LC-MS/MS method has been developed to determine xylometazoline concentration, which was 18.6 ng/mL in blood and 498.9 ng/mL in urine. The macroscopically detected hemorrhagic focus was confirmed by histopathological which confirmed hemorrhagic infarcts in the brain tissue, especially in the subarachnoid area. No other pathological changes were found. Based on findings from autopsy and toxicological analyses, the direct cause of death was concluded to be hemorrhagic stroke resulting from xylometazoline intoxication. Although xylometazoline products are regarded as relatively safe and are available over the counter, the risk of adverse effects, in particular stroke leading to death, should be considered. If adverse effects are observed, it is reasonable to measure the concentration of the drug in blood and urine. With such data, it will be possible to assess the actual exposure to this xenobiotic and draw firmer conclusions.


  • Open Access

    Histamine and Serotonin Levels in Bone Marrow Stem Cells Niche as Potential Biomarkers of Systemic Mastocytosis and Myeloproliferative Disorders

    by Tomasz Janus, Urszula Korbal, Maciej Żukowski, Agnieszka Lewosiuk, Katarzyna Koper, Agnieszka Żukowska, Katarzyna Brzeźniakiewicz-Janus

    Bone marrow studies currently provide a lot of valuable information in the diagnostics of hematological diseases including hematopoietic stem cells disorders. Our studies on low-molecular weight organic compounds in bone marrow stem cell niche in various pathogenic conditions, revealed relatively high variability of histamine levels in different groups of hematological diseases. It was also found that serotonin levels were significantly lower than those typically measured in peripheral blood as well as many have the influence on stem cells proliferative potential. This paper presents findings from quantitative and statistical analyses of histamine and serotonin levels. Bone marrow collected from patients undergoing routine diagnostic procedures for hematological diseases and receiving inpatient treatment were analyzed. Histamine and serotonin levels were measured using hydrophilic interaction liquid chromatography (HILIC) coupled with tandem mass spectrometry. Obtained data were analyzed statistically and correlated with the diagnosed groups of hematological diseases and the parameters of complete blood counts. Histamine was found in all tested samples, including those from patients without malignancy, and the reported levels were comparable to the reference values in blood. This observation allows us to assume that bone marrow cells can produce and accumulate histamine. Moreover, the statistical analysis revealed a significant relationship between histamine levels and diagnosed mastocytosis, and between histamine levels and myeloproliferative neoplasms. Different results were obtained for serotonin, and its concentrations in most cases were below the limit of quantification of the method used (< 0.2 ng/mL), which can only be compared to peripheral blood plasma. In a few cases, significantly higher serotonin levels were observed and it concerned diseases associated with an increased number of megakaryocytes in the bone marrow.


  • Open Access

    Psychoactive substances and road traffic safety in Szczecin, Poland between 2016 and 2020

    by Barbara Potocka-Banaś, Urszula Semeniuk, Tomasz Janus, Krzysztof Borowiak

    Introduction: Road traffic safety depends on the road surface, weather, and the driver’s behaviour on the road. Safety primarily depends on the behaviour of drivers, who often violate the law and, for example, exceed the speed limit, use a mobile phone while driving, or run red lights at intersections. Another problem for road safety is drivers operating vehicles under the influence of alcohol and/or other psychoactive substances such as amphetamine and its analogues, delta-9-tetrahydrocannabinol (Δ-9-THC), cocaine, opioids and benzodiazepines. The study aimed to analyze data obtained from blood tests performer on drivers stopped for roadside checks by police officers in Szczecin in the years 2016–2020 (West Pomerania province).Materials and methods: Secured blood samples were analyzed for the type and concentration of specific psychoactive substances which were initially detected in drivers during roadside checks. Quantitative blood tests were carried out using liquid chromatography mass spectrometry (LC/MS).Results: In 2016–2020, 1,607 drivers were tested at the Department of Clinical and Forensic Toxicology of the Pomeranian Medical University in Szczecin. Records indicated that each year, the rate of road users who were under the influence of a psychoactive substance as defined by law was increasing. The analysis revealed that the most frequently detected substance was amphetamine in 2017 (61%), 2018 (48%) and 2020 (48%), and Δ-9-THC in 2016 and 2019 (48%).Conclusions: In the analyzed period, in contrast to the numer of drivers testing positive for amphetamine and Δ-9-THC, the rate of road users testing positive for opiates, cocaine or benzodiazepines in blood was relatively low.

  • Open Access

    Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications

    by Urszula Adamiak-Giera, Wojciech Jawień, Anna Pierzchlińska, Monika Białecka, Jan Dariusz Kobierski, Tomasz Janus, Barbara Gawrońska-Szklarz

    Parkinson’s disease (PD) is a progressive, neurodegenerative disorder primarily affecting dopaminergic neuronal systems, with impaired motor function as a consequence. The most effective treatment for PD remains the administration of oral levodopa (LD). Long-term LD treatment is frequently associated with motor fluctuations and dyskinesias, which exert a serious impact on a patient’s quality of life. The aim of our study was to determine the pharmacokinetics of LD: used as monotherapy or in combination with ropinirole, in patients with advanced PD. Furthermore, an effect of ropinirole on the pharmacokinetics of 3-OMD (a major LD metabolite) was assessed. We also investigated the correlation between the pharmacokinetic parameters of LD and 3-OMD and the occurrence of motor complications. Twenty-seven patients with idiopathic PD participated in the study. Thirteen patients received both LD and ropinirole, and fourteen administered LD monotherapy. Among 27 patients, twelve experienced fluctuations and/or dyskinesias, whereas fifteen were free of motor complications. Inter- and intra-individual variation in the LD and 3-OMD concentrations were observed. There were no significant differences in the LD and 3-OMD concentrations between the patients treated with a combined therapy of LD and ropinirole, and LD monotherapy. There were no significant differences in the LD concentrations in patients with and without motor complications; however, plasma 3-OMD levels were significantly higher in patients with motor complications. A linear one-compartment pharmacokinetic model with the first-order absorption was adopted for LD and 3-OMD. Only mean exit (residence) time for 3-OMD was significantly shorter in patients treated with ropinirole. Lag time, V/F, CL/F and tmax of LD had significantly lower values in patients with motor complications. On the other hand, AUC were significantly higher in these patients, both for LD and 3-OMD. 3-OMD Cmax was significantly higher in patients with motor complications as well. Our results showed that ropinirole does not influence LD or 3-OMD concentrations. Higher 3-OMD levels play a role in inducing motor complications during long-term levodopa therapy.


  • Open Access

    Selected Hematological Biomarkers to Predict Acute Mortality in Emergency Department Patients. Recent Polish Hospital Statistics

    by Katarzyna Brzeźniakiewicz-Janus, Marcus Daniel Lancé, Andrzej Tukiendorf, Tomasz Janus, Mirosław Franków, Joanna Rupa-Matysek, Zuzanna Walkowiak, Lidia Gil

    Background.Complete blood count (CBC), red cell distribution width (RDW), mean platelet volume (MPV), mean corpuscular volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), or platelet (PLT) count are referred as predictors of adverse clinical outcomes in patients. The aim of the research was to identify potential factors of acute mortality in Polish emergency department (ED) patients by using selected hematological biomarkers and routine statistical tools. Methods. The study presents statistical results on patients who were recently discharged from inpatient facilities within one month prior to the index ED visit. In total, the analysis comprised 14,881 patients with the first RDW, MPV, MCV, MCH, MCHC, or PLT biomarkers' measurements recorded in the emergency department within the years 2016-2019 with a subsequent one month of all-cause mortality observation. The patients were classified with the codes of the International Statistical Classification of Diseases and Related Health Problems after 10(th) Revision (ICD10). Results. Based on the analysis of RDW, MPV, MCV, MCH, MCHC, and PLT on acute deaths in patients, we establish strong linear and quadratic relationships between the risk factors under study and the clinical response (P95 fL), whereas MCH, MCHC, and PLT have no impact on the excess acute mortality in ED patients.


  • Open Access

    CEDIA method in amphetamine and cannabinoid analysis – potential applications in forensic toxicology blood tests

    by Urszula Semeniuk, Barbara Potocka-Banaś, Ewa Jasionowicz, Krzysztof Borowiak, Tomasz Janus

    Introduction: Immunoassays are the 1st stage of clinical and forensic toxicology examinations.The aim of the research was to evaluate the suitability of CEDIA (cloned enzyme donor immmunoassay) for the detection of selected drugs such as amphetamine, tetrahydrocannabinol (THC) metabolite: tetrahydrocanabinolic acid (11-nor-9-carboxy-Δ9-tetrahydrocannabinol – THC-COOH).Materials and methods: Blood samples were examined for the presence of the selected psychoactive drugs, similar in effect to alcohol. Whole blood samples were centrifuged, and the obtained plasma was analysed using CEDIA and LC-MS/MS.Results: We observed a strong correlation between amphetamine levels measured with CEDIA and the reference technique (LC-MS/MS), and a lack correlation for THC-COOH levels. Cloned enzyme donor immmunoassay did not provide false positive results – positive samples in CEDIA were also positive in LC-MS/MS, which demonstrated the high specificity of CEDIA.Conclusions: Considering the high specificity in tests for amphetamine and cannabinoids, CEDIA can be used as a qualitative method in forensic and clinical analysis. This study demonstrates a linearity only for amphetamine detection, which may suggest the need for further verification of the results of other assays offered by the manufacturer. Only serum/plasma can be analysed with CEDIA, which makes this technique unsuitable for highly degraded samples.Keywords: immunoenzyme techniques; screening methods; CEDIA; LC-MS/MS; psychoactive drugs.

  • Open Access

    Intoxication with new psychoactive substances in patients diagnosed at the Department of Clinical and Forensic Toxicology, Pomeranian Medical University in Szczecin in 2015–2018

    by Barbara Potocka-Banaś, Urszula Semeniuk, Sławomir Majdanik, Krzysztof Borowiak, Tomasz Janus

    Introduction: Intoxication with new psychoactive substances (NPSs), colloquially known as designer drugs, has become a significant problem in the last several years. The aim of the study was to conduct a statistical analysis of retrospective data from test records for the presence of NPSs in patients hospitalized in 2015–2018 in the West Pomeranian province. Materials and methods: We analyzed 5,916 results of tests undertaken at the Department of Clinical and Forensic Toxicology at Pomeranian Medical University in Szczecin. Blood samples had been analyzed by liquid chromatography coupled with mass spectrometry (LC/MS) and Headspace gas chromatography (GC/Headspace). Results: Our research was based on 5,916 diagnostic tests for poisoning with volatile and non-volatile organic compounds carried out in 2015–2018 at Pomeranian Medical University in Szczecin. Psychoactive substances used for non-medical purposes were detected in 1,465 patients. In the period under analysis 1,328 of these patients were poisoned with classic psychoactive substances, the poisonings caused by the intentional use NPS were recorded in 137. Conclusions: A retrospective analysis of the above-mentioned data for the period 2015–2018 revealed a gradual increase in the incidence of poisoning with psychoactive substances used for non-medical purposes. Keywords: intoxication; new psychoactive substances; designer drugs; data analysis; diagnostic tests.


  • Open Access

    Red Blood Cells Mean Corpuscular Volume (MCV) and Red Blood Distribution Width (RDW) Parameters as Potential Indicators of Regenerative Potential in Older Patients and Predictors of Acute Mortality – Preliminary Report

    by Katarzyna Brzeźniakiewicz-Janus, Joanna Rupa-Matysek, Andrzej Tukiendorf, Tomasz Janus, Mirosław Franków, Marcus Daniel Lancé, Lidia Gil

    This study presents the statistical results of patients who had been recently discharged from hospital within one month after their treatment in the emergency department (ED). Using routine (14,881) MCV and RDW measurements and statistical tools, we could predict acute mortality in these patients (N = 1158), adjusted for age. It is likely that an increase in the MCV and RDW parameters may correlate in some of our older patients with a poor prognosis with an increased level of circulating IGF–I, which affects red blood cell parameters. The research presents the prognostic statistics of the analyzed clinical factors as well as speculates on the potential correlation of these parameters with the regenerative potential of stem-cell compartment. Analysis shows that both MCV and RDW are statistically significant (Area Under Curve [AUC], lower CI 95% >50%) predictors of acute mortality in ED patients. The classification of patients based on their MCV threshold (= 92.2 units) indicates a proper clinical prognosis in nearly 6 of 10 subjects (AUC >58%), whereas taking into account RDW (=13.8%) indicates a proper clinical prognosis in no more than 7 of 10 individuals. The report concludes that by employing strongly fitting (95%) quadratic modeling of the ORs against the biomarkers studied, one can notice a similar relationship between MCV and RDW as diagnostic tools to predict regenerative potential and clinical outcomes in older patients. Although RDW alone had a 10% higher diagnostic value in terms of predicting early death in the emergency department in patients that were admitted to the ED and subsequently hospitalized, also taking the MCV measurement improved accuracy in predicting clinical outcomes by 2.5% compared to RDW alone.


  • Open Access

    Analiza toksykologiczna peptydów w materiale biologicznym z wykorzystaniem spektrometrii mas na przykładzie oznaczania alfa-amanityny

    by Tomasz Janus, Ewa Jasionowicz, Barbara Potocka-Banaś, Krzysztof Borowiak

    Introduction: Routine toxicological analysis is mostly focused on the identification of non-organic and organic, chemically different compounds, but generally with low mass, usually not greater than 500–600 Da. Peptide compounds with atomic mass higher than 900 Da are a specific analytical group. Several dozen of them are highly-toxic substances well known in toxicological practice, for example mushroom toxin and animal venoms. In the paper the authors present an example of alpha-amanitin to explain the analytical problems and different original solutions in identifying peptides in urine samples with the use of the universal LC MS/MS procedure. Materials and methods: The analyzed material was urine samples collected from patients with potential mushroom intoxication, routinely diagnosed for amanitin determination. Ultra filtration with centrifuge filter tubes (limited mass cutoff 3 kDa) was used. Filtrate fluid was directly injected on the chromatographic column and analyzed with a mass detector (MS/MS). Results: The separation of peptides as organic, amphoteric compounds from biological material with the use of the SPE technique is well known but requires dedicated, specific columns. The presented paper proved that with the fast and simple ultra filtration technique amanitin can be effectively isolated from urine, and the procedure offers satisfactory sensitivity of detection and eliminates the influence of the biological matrix on analytical results. Another problem which had to be solved was the non-characteristic fragmentation of peptides in the MS/MS procedure providing non-selective chromatograms. It is possible to use higher collision energies in the analytical procedure, which results in more characteristic mass spectres, although it offers lower sensitivity. Conclusions: The ultra filtration technique as a procedure of sample preparation is effective for the isolation of amanitin from the biological matrix. The monitoring of selected mass corresponding to transition with the loss of water molecule offers satisfactory sensitivity of determination